Treosulfan impedes the migration of immunocompetent cells [7]

Journal of Neurology

Volumn 254, Issue 10, 2007, Pages 1457-1458

  Kopadze, T ^a   Dehmel, T ^a   Mylius, H A ^b   Hartung, H P ^a   Wiendl, H ^c   Kieseier, B C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MEDAC GMBH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FIBRONECTIN; MEDAC; MITOXANTRONE; PHYTOHEMAGGLUTININ; TREOSULFAN; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MIGRATION; CYTOMETRY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LETTER; MICROSCOPY; MONOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; CELL MOVEMENT; HUMANS; LEUKOCYTES, MONONUCLEAR;

EID: 36148963286     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0552-5     Document Type: Letter

References (6)

1. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP (2006) Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2:201-211
2. Kopadze T, Dehmel T, Hartung HP, Stüve O, Kieseier BC (2006) Mitoxantrone inhibits in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis. Arch Neurol 63:1572-1578
3. Stuve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, Yong VW (1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40:853-863
4. Weissert R, Wiendl H, Pfrommer H, Storch MK, Schreiner B, Barth S, Seifert T, Melms A, Dichgans J, Weller M (2003) Action of treosulfan in myelin-oligodendrocyte- glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes. J Neuroimmunol 144:28-37
5. Wiendl H, Kieseier BC (2003) Diseasemodifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies. Expert Opin Investig Drugs 12:689-712
6. Wiendl H, Kieseier BC, Weissert R, Mylius HA, Pichlmeier U, Hartung HP, Melms A, Kuker W, Weller M (2007) Treatment of active secondary progressive multiple sclerosis with treosulfan. J Neurol Epub ahead of print DOI 10.1007/s00415-006-0459-6